James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 4,500 shares at $72.08 ($326K) on 2019-09-09, disclosed to the SEC on 2019-09-11.
Open-market sale of $326k GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.08 | 3,000 | $216K | 66.3% |
| 2 | $73.24 | 1,300 | $95K | 29.2% |
| 3 | $74.13 | 200 | $15K | 4.5% |
| Total | $72.50 avg | 4,500 | $326K | 100% |
| Filing → |
| GHDX | SELL | 2019-05-10 | $421K | — | Filing → |
| GHDX | SELL | 2018-10-10 | $3.2M | — | Filing → |
| GHDX | SELL | 2018-06-06 | $4.3M | — | Filing → |